<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Early, low-risk International Prognostic Scoring System (IPSS) <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> disorder where the molecular and cellular hematopoietic defects are poorly understood </plain></SENT>
<SENT sid="1" pm="."><plain>To gain insight into this condition, we analyzed gene expression profiles of marrow CD34+ progenitor cells from <z:mpath ids='MPATH_458'>normal</z:mpath>-karyotype, low-blast-count <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, age-matched controls, and patients with non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Given the <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of early <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, a surprisingly consistent finding was decreased expression of B-cell lineage-affiliated genes in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients compared with healthy controls and 3 of 5 samples with non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Both patients with non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> <z:hpo ids='HP_0001903'>anemia</z:hpo> with reduced B-cell gene expression were on chemotherapy </plain></SENT>
<SENT sid="4" pm="."><plain>In 25 of 27 of the original samples and 9 further <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> samples, Taqman real-time polymerase chain reaction (PCR) confirmed these data </plain></SENT>
<SENT sid="5" pm="."><plain>Flow cytometry on unfractionated marrow from independent samples also demonstrated reduced B-cell progenitors in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients compared with healthy controls </plain></SENT>
<SENT sid="6" pm="."><plain>These novel findings suggest a common perturbation in early <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> hematopoiesis </plain></SENT>
<SENT sid="7" pm="."><plain>They also provide the rationale for a larger study to evaluate the diagnostic utility of reduced B-cell progenitor number as a diagnostic biomarker of early low-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, which can pose a diagnostic challenge </plain></SENT>
</text></document>